What is NanoImaging Services?
NanoImaging Services operates at the intersection of advanced imaging technology and pharmaceutical development, offering specialized cryo-electron microscopy (cryo-EM) services. The company's core mission is to accelerate drug discovery by providing critical structural biology insights. Their comprehensive service portfolio includes nanoparticle characterization and GMP-compliant imaging, all supported by state-of-the-art in-house microscopy facilities. The recent acquisition of Proteos, a prominent protein production CRO, further bolsters NIS's integrated service offerings, positioning them as a key partner for pharmaceutical and biotechnology firms seeking cutting-edge solutions for their drug development pipelines.
How much funding has NanoImaging Services raised?
NanoImaging Services has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for NanoImaging Services?
With its recent capital infusion and strategic acquisition, NanoImaging Services is poised for significant expansion. The company's focus on cryo-EM and structural biology places it in a high-growth segment of the life sciences services market. This late-stage funding context suggests NIS is likely scaling its operations, enhancing its technological capabilities, and potentially broadening its client base within the global pharmaceutical and biotechnology sectors. The integration of Proteos' protein production expertise is expected to create a more seamless workflow for clients, from target identification to structural analysis, thereby solidifying NIS's competitive advantage.
See full NanoImaging Services company page
